Patriot Financial Group Insurance Agency, LLC Crispr Therapeutics Ag Transaction History
Patriot Financial Group Insurance Agency, LLC
- $795 Million
- Q2 2025
A detailed history of Patriot Financial Group Insurance Agency, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Patriot Financial Group Insurance Agency, LLC holds 23,195 shares of CRSP stock, worth $1.53 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
23,195
Previous 22,745
1.98%
Holding current value
$1.53 Million
Previous $774,000
45.74%
% of portfolio
0.14%
Previous 0.11%
Shares
30 transactions
Others Institutions Holding CRSP
# of Institutions
478Shares Held
64MCall Options Held
2.16MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$670 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$400 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$250 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$183 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.54MShares$167 Million0.06% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.14B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....